Clinical Trial Update: Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial of memantine-enhanced buprenorphine treatment for opioid dependence completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• Memantine (memantine)
• buprenorphine (buprenorphine)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Opioid Dependence | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-03-06